Innovative technology demands an innovative CRO. Founded in 2003, Pharmaseed is the largest Israel-based GLP-certified preclinical and early clinical CRO, providing preclinical, early clinical, and consulting services for medical device, biotechnology, and pharmaceutical companies. Pharmaseed also provides pre-formulation services for small and medium-size startups as well as companies in the idea and feasibility stages. Pharmaseed's core competencies include: - CNS (stroke, Parkinson's, Alzheimer's, schizophrenia, etc.), - Cancer (xenograft, orthotopic and human tissue samples) - Pain (neuropathic, acute, chronic) - Inflammation (acute, chronic) - Metabolism (diabetes, other) - Stem cell research - Cannabis With over 20 years of experience, the experienced Pharmaseed team knows how to balance creativity and flexibility while maintaining the highest ethical and quality standards. The majority of our team members are PhD and postdoc-level researchers who have held key positions in the life sciences industry, with facilities including a state-of-the-art in-house lab and vivarium, BSL-2 safety unit, in- vitro lab, and more. We are equipped for NCE studies, biologics and medical-devices as well as conducting and following through from the development stage to first-in-human trials. These studies include safety and efficacy evaluation in various animal models, in addition to complementary in-vitro/ex-vivo models and on- site human anatomy services. Pharmaseed’s high-end one-stop-shop RD services offer very competitive rates alongside in-depth expert knowledge, enabling your initial ideas to be transformed into real sustainable technologies.